Research institute in
Bellinzona

15 companies in Research institute based in Bellinzona — name and year of registration from the commercial register. The list below shows them all.

Companies

All 15 companies in Bellinzona

Fondazione per l'istituto di Ricerca in Biomedicina (IRB)

Since 1997 · 21–50 empl.4.7(47)

Fondazione per l'istituto di Ricerca in Biomedicina (IRB) operates a non-profit institute for biomedical research and graduate teaching. Its research examines human biology in health and disease, including immunology, infectious diseases, inflammation, degenerative conditions and tumours.

Research instituteBasic and translational biomedicine researchCore facilities for biomedical researchInternational doctoral training

Fondazione per la ricerca sul cancro nel Ticino

Since 1985 · 11–20 empl.

Fondazione per la ricerca sul cancro nel Ticino funds scientific research projects in oncology and awards research scholarships and a prize. The foundation operates in coordination with Lega cancro Ticino, which by statute holds the majority of seats on the foundation board and supports the allocation of grants to researchers domiciled or active in the canton.

Research instituteFunding for oncological research projectsMario Luvini Research ScholarshipDick Marty Research Award

Tecnomedia Service Sagl

Since 1994 · 1–10 empl.

Tecnomedia Service Sagl provides external technical support to businesses on an ongoing basis. Its services include programming and system configuration, the development and prototyping of custom electronic and software solutions, and technical consulting and audits.

Research instituteOngoing technical supportProgramming and parametrisationDevelopment and prototyping

Fondazione Sir John Eccles

Since 2003 · 11–20 empl.

Fondazione Sir John Eccles promotes studies and scientific and philosophical research on subjects explored by Sir John Eccles, particularly the relationship between mind and brain. It organizes interdisciplinary activities in neurohumanities and may support research programmes and publications.

Research institutePromotion of activities, studies and scientific and philosophical researchInterdisciplinary symposiaSir John Eccles Lectures

Humabs BioMed SA

Since 2011 · 11–20 empl.

The core activity of Humabs BioMed SA is the discovery and development of anti-infective immunotherapies for the treatment of viral and bacterial diseases, including those caused by Zika, Ebola, Rabies, Dengue and other Flaviviruses. The company focuses on the development of therapeutics up to clinical proof of concept and has a broad pipeline of development candidates.

Research instituteDevelopment of ImmunotherapiesAntibody and T-cell Engager Development PlatformPRO-XTEN® Masking Platform

MV BioTherapeutics SA

Since 2018 · 11–20 empl.

MV BioTherapeutics SA is a biotherapeutics company developing modified microorganisms and recombinant proteins for therapeutic applications. Its ApyraMed and ApyraVax platforms aim to modulate the intestinal ecosystem and mucosal immune responses, with programs addressing inflammatory bowel disease, cancer immunotherapy and protection against infections.

Research instituteApyraMedApyraVaxDevelopment programmes

Bios plus

Since 2021 · 21–50 empl.

Bios plus is a non-profit association that promotes, supports and coordinates its members’ research and teaching activities. It fosters scientific, organizational and administrative synergies and aims to establish a life sciences research center.

Research institutePromotion, support and coordinationOrganisation of scientific events and outreachReception of institutional visits and external collaborations

Fondazione per l'Istituto Oncologico di Ricerca (IOR)

Since 1999 · 101–500 empl.3.8(4)

Fondazione per l'Istituto Oncologico di Ricerca (IOR) runs the Institute of Oncology Research (IOR), which conducts basic and translational oncology research. Its research covers cancer biology, genomics, molecular oncology and experimental therapeutics, with a focus on lymphomas and epithelial cancers.

Research instituteBasic and translational cancer researchResearch services and infrastructureScientific training and doctorate